XML 14 R2.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 63,547 $ 417,195
Investments in marketable securities 128,134  
Trade receivables, net 109,964 123,022
Inventory 38,791 37,642
Prepaid manufacturing 17,880 13,666
Other prepaids and current assets 22,918 10,798
Total current assets 381,234 602,323
Property and equipment, net 8,754 7,813
Inventory, non-current 76,260 55,610
Goodwill and intangible assets 5,931 3,563
Other assets, non-current 8,668 10,025
Total assets 480,847 679,334
Current liabilities:    
Accounts payable 11,526 16,159
Accrued rebates, fees and reserves 54,461 79,027
Accrued compensation 22,610 22,014
Accrued and other current liabilities 50,097 48,127
Total current liabilities 138,694 165,327
Term loans 245,483 75,513
Convertible notes 225,575 332,767
Lease liabilities, non-current 5,046 7,251
Other liabilities, non-current 3,467 750
Total liabilities 618,265 581,608
Commitments and contingencies (Note 8)
Stockholders' equity (deficit):    
Common stock ($0.0001 par value; shares authorized: 300,000,000; shares issued and outstanding: 78,851,516 and 76,930,096 at December 31, 2022 and 2021, respectively) 8 7
Additional paid-in capital 1,204,431 1,147,843
Accumulated other comprehensive loss (249) (270)
Accumulated deficit (1,341,608) (1,049,854)
Total stockholders' equity (deficit) (137,418) 97,726
Total liabilities and stockholders' equity (deficit) $ 480,847 $ 679,334